Work

Quantifying Renal And Tumor Doses with Individualized Dosimetry In 177Lu DOTATATE Therapy – What Difference Does It Make?

Year: 2019

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2019.06.273

Authors: R. Wong, D. Laidley, S.D. Myrehaug, J. Brierley, R. Juergens, I.W.T. Yeung, S. Breen, B. Driscoll, A. Shessel, T. Farncombe, K. Zukotynski, R. Stodilka, C.B. Caldwell, Z. Liu, J. Valliant, J. McCann, U. Metser, R. Mohan, J.M. Beauregard, D.A. Jaffray

Institutions: University Health Network, University of Toronto, Princess Margaret Cancer Centre, Western University, London Health Sciences Centre, Sunnybrook Health Science Centre, Odette Cancer Centre, McMaster University, Southlake Regional Health Center, Hamilton Health Sciences, Centre for Probe Development and Commercialization, CHU de Québec-Université Laval

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2973057084

FWCI:

Cites:

Cited by:

Related to: 10